[EN] HETEROARYL RHEB INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE RHEB À BASE D'HÉTÉROARYLE ET LEURS UTILISATIONS
申请人:NAVITOR PHARM INC
公开号:WO2018191146A1
公开(公告)日:2018-10-18
The present invention provides compounds, compositions thereof, and methods of using the same. Compositions comprising a compound of this invention or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The amount of the compound in compositions of this invention is such that it is effective to measurably inhibit Rheb, in a biological sample or in a patient.
There are provided novel substituted aniline intermediates, useful in the synthesis of certain substituted N-nitroanilines or salts thereof which may be used to elicit several desirable and advantageous biological responses in plants.
The present invention provides compounds of general Formula I and I′:
compositions thereof, and methods of using same to treat Rheb-mediated disorders.
本发明提供通式I和I′的化合物:
其组合物,以及用其治疗 Rheb 介导的疾病的方法。
HETEROARYL RHEB INHIBITORS AND USES THEREOF
申请人:Navitor Pharmaceuticals, Inc.
公开号:US20210238165A1
公开(公告)日:2021-08-05
The present invention provides compounds, compositions thereof, and methods of using the same. Compositions comprising a compound of this invention or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The amount of the compound in compositions of this invention is such that it is effective to measurably inhibit Rheb, in a biological sample or in a patient.